HRPK20010470B1 - The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life - Google Patents

The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life

Info

Publication number
HRPK20010470B1
HRPK20010470B1 HR20010470A HRP20010470A HRPK20010470B1 HR PK20010470 B1 HRPK20010470 B1 HR PK20010470B1 HR 20010470 A HR20010470 A HR 20010470A HR P20010470 A HRP20010470 A HR P20010470A HR PK20010470 B1 HRPK20010470 B1 HR PK20010470B1
Authority
HR
Croatia
Prior art keywords
utilisation
medicament
inhibitors
producing
sodium hydrogen
Prior art date
Application number
HR20010470A
Other languages
English (en)
Inventor
Wolfgang Linz
Hans Jochen Lang
Bela Kelety
Peter Schmid
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HRP20010470A2 publication Critical patent/HRP20010470A2/hr
Publication of HRPK20010470B1 publication Critical patent/HRPK20010470B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
HR20010470A 1998-12-23 2001-06-20 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life HRPK20010470B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859727A DE19859727A1 (de) 1998-12-23 1998-12-23 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
PCT/EP1999/009621 WO2000038661A2 (de) 1998-12-23 1999-12-08 Die verwendung von hemmern des natrium-wasserstoff-austauschers zur herstellung eines medikaments zur verhinderung von altersbedingten organ-dysfunktionen, altersbedingten erkrankungen und zur lebensverlängerung

Publications (2)

Publication Number Publication Date
HRP20010470A2 HRP20010470A2 (en) 2002-06-30
HRPK20010470B1 true HRPK20010470B1 (en) 2003-10-31

Family

ID=7892436

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010470A HRPK20010470B1 (en) 1998-12-23 2001-06-20 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life

Country Status (20)

Country Link
US (1) US6420430B1 (tr)
EP (1) EP1140056A2 (tr)
JP (1) JP2002533386A (tr)
KR (1) KR20010086152A (tr)
CN (1) CN1367689A (tr)
AR (1) AR021965A1 (tr)
AU (1) AU776761B2 (tr)
BR (1) BR9916505A (tr)
CA (1) CA2357837A1 (tr)
CZ (1) CZ20012309A3 (tr)
DE (1) DE19859727A1 (tr)
HR (1) HRPK20010470B1 (tr)
HU (1) HUP0104652A3 (tr)
IL (1) IL143372A0 (tr)
NO (1) NO20013145L (tr)
RU (1) RU2238721C2 (tr)
SK (1) SK9042001A3 (tr)
TR (1) TR200101803T2 (tr)
WO (1) WO2000038661A2 (tr)
ZA (1) ZA200104301B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
RU2004126702A (ru) * 2002-02-04 2005-04-20 АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
NZ544671A (en) * 2003-06-26 2009-02-28 Biotron Ltd Antiviral compounds and methods
US7947897B2 (en) * 2005-11-02 2011-05-24 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8013240B2 (en) * 2005-11-02 2011-09-06 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8017863B2 (en) * 2005-11-02 2011-09-13 The Regents Of The University Of Michigan Polymer wrapped carbon nanotube near-infrared photoactive devices
KR101042078B1 (ko) * 2009-01-13 2011-06-16 한국항공우주산업 주식회사 치공구 제작용 수평 측면 가공 치구
CN104103253B (zh) 2014-07-04 2016-08-17 京东方科技集团股份有限公司 发射电极扫描电路、阵列基板和显示装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
ATE198328T1 (de) * 1992-09-28 2001-01-15 Hoechst Ag Antiarrhythmische und cardioprotektive substituierte 1(2h)-isochinoline, verfahren zu deren herstellung, diese enthaltende arzneimittel und ihre anwendung für die herstellung eines arzneimittels zur behandlung von herzinsuffizienzen
SE508028C2 (sv) * 1993-05-12 1998-08-10 Moelnlycke Ab Midjebälte för absorberande plagg
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE69501219T2 (de) 1994-02-25 1998-04-16 Microtecnica Elektrolyt-aktivierte Batterie
DE4430861A1 (de) 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19502644A1 (de) 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
ATE183498T1 (de) * 1995-04-18 1999-09-15 Hoechst Ag Substituierte indenoylguanidines mit antiarrhythmischer und cardioprotektiver wirkung
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
CA2260499A1 (en) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Pharmaceutical compositions for the treatment of ischemic brain damage

Also Published As

Publication number Publication date
ZA200104301B (en) 2003-02-20
HRP20010470A2 (en) 2002-06-30
JP2002533386A (ja) 2002-10-08
AU776761B2 (en) 2004-09-23
HUP0104652A2 (hu) 2002-03-28
WO2000038661A3 (de) 2000-11-09
SK9042001A3 (en) 2001-12-03
NO20013145L (no) 2001-08-22
EP1140056A2 (de) 2001-10-10
CN1367689A (zh) 2002-09-04
AU1657600A (en) 2000-07-31
IL143372A0 (en) 2002-04-21
CA2357837A1 (en) 2000-07-06
AR021965A1 (es) 2002-09-04
US6420430B1 (en) 2002-07-16
CZ20012309A3 (cs) 2001-09-12
WO2000038661A2 (de) 2000-07-06
RU2238721C2 (ru) 2004-10-27
BR9916505A (pt) 2001-11-20
TR200101803T2 (tr) 2001-10-22
NO20013145D0 (no) 2001-06-22
DE19859727A1 (de) 2000-06-29
KR20010086152A (ko) 2001-09-08
RU2001120358A (ru) 2005-12-10
HUP0104652A3 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
HUP0104652A3 (en) The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life
GB9913756D0 (en) New O-acyloxime photoinitiators
GB9717718D0 (en) Memory management with compaction of data blocks
HUP0101613A3 (en) Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same
GB9900396D0 (en) Arrangements of electrochemical cells
HUP0300195A3 (en) Heterocyclic sodium/proton exchange inhibitors and pharmaceutical compositions containing them
ZA974828B (en) Use of inhibitors of the cellular Na<+>/H<+> exchanger (NHE) for the production of a medicament for the normalization of serum lipids.
TW511729U (en) Structure of computer casing
HUP0200222A2 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds and pharmaceutical compositions containing them
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
ZA987723B (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases
IL125114A0 (en) Use of inhibitor of the cellular na+/h+ exchanger (nhe) for the production of a medicament for respiratory stimulation
AU3110500A (en) Cell matrix plaques of initial bone formation
GB9900398D0 (en) Arrangements of electrochemical cells
HK1024472A1 (en) An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors
EP1009047A4 (en) BATTERY PLATE AND BATTERY
AU139957S (en) Abdominal pad having thermal cells
DZ3463A1 (fr) Cristaux d'inhibiteurs de l'echangeur sodium-hydrogene de type 1
AU1959200A (en) New utilization of alpha-hidroxy-propionic acid in medicine
EP1061980A4 (en) NON-INTRACTIVE METABOLIC GAS AND HEART RATE EXCHANGE MONITORING APPARATUS
GB9700233D0 (en) Use of glycosidase inhibitors
TW361329U (en) New design of ratchet wrench with double face and twin size
TW390543U (en) Improved structure of cassette trumpet power distribution flexible pipe head
TW502838U (en) Improved combining structure for cassette case of a personal computer
TW390552U (en) Structure of wire-tying strip for power supply

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20041019

Year of fee payment: 6

PBKO Lapse due to non-payment of renewal fee for consensual patent

Effective date: 20051209